Detailed answers about ABMED MEDICAL TECHNOLOGY LTD, including incorporation, status, business activity, and accounts information.
When was ABMED MEDICAL TECHNOLOGY LTD founded?
ABMED MEDICAL TECHNOLOGY LTD was officially incorporated on 20 June 2024 and is registered under company number 15789863. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ABMED MEDICAL TECHNOLOGY LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ABMED MEDICAL TECHNOLOGY LTD?
ABMED MEDICAL TECHNOLOGY LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ABMED MEDICAL TECHNOLOGY LTD do?
ABMED MEDICAL TECHNOLOGY LTD operates in the following sectors: 32500 - Manufacture of medical and dental instruments and supplies, 46180 - Agents specialized in the sale of other particular products, 46690 - Wholesale of other machinery and equipment, 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is ABMED MEDICAL TECHNOLOGY LTD's registered address?
The registered office address of ABMED MEDICAL TECHNOLOGY LTD is 52A WESTERHAM ROAD, SEVENOAKS, KENT, TN13 2PZ. This is the official address filed with Companies House for legal and statutory correspondence.
Is ABMED MEDICAL TECHNOLOGY LTD financially stable?
Financial accounts for ABMED MEDICAL TECHNOLOGY LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.